Discriminated benefits of a mediterranean dietary pattern within a hypocaloric diet program on plasma rbp4 concentrations and other inflammatory markers in obese subjects.

Auteur(s) :
Zulet MA., Hermsdorff HH., Abete I., Martinez JA.
Date :
Déc, 2009
Source(s) :
Endocrine. #36:3 p445-451
Adresse :
Department of Nutrition and Food Sciences, Physiology and Toxicology, Institute of Nutrition and Food Sciences, University of Navarra, C/Irunlarrea, 1, Pamplona, 31008, Spain.

Sommaire de l'article

Personalized nutritional strategies to treat obesity may specifically influence inflammatory markers, in addition to reduce body weight. In the present study, we evaluated the effect of a hypocaloric diet based on a Mediterranean dietary pattern (MDP) on nutritional status as well as on plasma concentrations of retinol binding protein-4 (RBP4) and other proinflammatory markers. Fourty-one subjects (24F/17M; age: 37 +/- 7 years; BMI: 32.2 +/- 3.9 kg/m(2)) were assigned to follow a MDP within a caloric-restricted diet over an 8-week period. Anthropometrical, clinical, and biochemical variables were measured at baseline and endpoint after the nutritional program. Dietary intervention resulted in a mean weight loss of -4.4 +/- 2.5 kg (P < 0.001) and marked reductions (P < 0.05) in plasma concentrations of RBP4, leptin, C-reactive protein, complement C3, and tumor necrosis factor-alpha (TNFalpha). Individuals with a higher adherence to the MDP during the nutritional intervention presented differentially higher reductions (P < 0.05) in plasma RBP4, IL6, and TNFalpha. In addition, the increase in the Mediterranean diet score from baseline was a significant and independent predictor factor for the decrease in plasma RBP4 concentration (P < 0.05). In conclusion, our findings suggest that following a hypocaloric diet accompanying a high adherence to a MDP resulted in specific reductions on proinflammatory markers, in addition to a significant improvement in some metabolic syndrome features induced by weight loss, which could be a good combined strategy to treat obesity as well as related metabolic and inflammatory disorders.

Source : Pubmed
Retour